DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20212942

Effect of COVID-19 lockdown on reproductive activity in Rivers state

Barinua K. Gbaranor, Humphrey N. Agara, Onisojime M. Alasia, William A. Mube, Iboroma Dumoateli, Blessing Z. Ovili-Odili, Sofiri S. Peterside, Vivian I. Ile

Abstract


Background: Reproductive activity is an important biological process that always take place between married and unmarried couples across the globe. The study was carried out to evaluate the effect of COVID-19 on reproductive activity during and post-lockdown in Rivers state. The aim of the study was to evaluate the effect of COVID-19 on reproductive activity during and post-lockdown in Rivers state.

Methods: A well-structured questionnaire containing demographics and effect of COVID-19 on reproductive activity were administered to participants. Each participant had one questionnaire to fill appropriately and independently after instructions were given to them by the researchers.

Results: The study revealed that 57.58% (57/99) of the participants were between the ages 16-20, 58.82% (60/102) were single and 99.03% (102/103) of the participants (women) have unprotected sexual intercourse during COVID-19 lockdown. 99.03% (102/103) the participants engaged in unprotected sex because the pharmacist’s stores were closed. The study also shows that 43.69% (103) have the urge for sex due to inactivity and 76.60% (102) of the participants got pregnant and 96.25% (77/80) of the pregnancy were not planned. 51.29% (41/80) of the participants aborted the pregnancy and 92.68% (38/41) 0f the women who got pregnant did not attend antenatal clinic.

Conclusions: A total number of 103 respondents participated in the research. 76.6% of the population got pregnant during the lockdown for different reasons and most of the participants were singles and did not plan for the pregnancy.

 


Keywords


Effect, COVID-19, Reproductive activity, Lockdown

Full Text:

PDF

References


CDC. COVID Tracker, 2021. Available at: https://www.cdc.gov/coronavirus/2019ncov/index.html. Accessed on 2 May 2021.

Godam ET, Olaniyan OT, Wofuru CD, Orupabo CD, Ordu KS, Gbaranor BK, et al. Xylopia aethiopica ethanol seed extract suppresses Cadmium chloride-induced ovary and gonadotropins toxicity in adult female Wistar rats. JBRA Assist Reprod. 2021;25(2):252-6.

Camara BS, Delamou A, Diro E, Beavogui AH, Ayadi AM, Sidibe S, et al. Effect of the 2014/2015 Ebola outbreak on reproductive health services in a rural district of Guinea: an ecological study. Trans R Soc Trop Med Hyg. 2017;111(1):22-9.

Chen L, Zhao J, Peng J, Li X, Deng X, Geng Z, et al. Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients. Cell Prolif. 2020;53(12):12923.

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.

Delamou A, Ayadi AME, Sidibe S, Delvaux T, Camara BS, Sandouno SD, et al. Effect of Ebola virus disease on maternal and child health services in Guinea: a retrospective observational cohort study. Lancet Glob Health. 2017;5(4):448-57.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7:11.

Papadimos TJ, Marcolini EG, Hadian M, Hardart GE, Ward N, Levy MM, et al. Ethics of outbreaks position statement. Part 2: family-centered care. Crit Care Med. 2018;46(11):1856-60.

Hoek L, Pyrc K, Jebbink MF, Vermeulen OW, Berkhout RJ, Wolthers KC, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368-73.

WHO. Novel coronavirus (2019-nCoV) situation reports, 2021. Available at: https://www.who.int/ emergencies/diseases/novelcoronavirus-2019/ situation-reports. Accessed on 2 May 2021.

WHO. Managing epidemics: key facts about major deadly diseases, 2021. https://www.who.int/ emergencies/diseases/managingepidemics/en/. Accessed on 1 May 2021.

WHO. Q&A on coronaviruses COVID (2000-19), 2021. Available at: https://www.who. int/news-room/q-a-detail/q-a-coronaviruses. Accessed on 2 May 2021.

Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589-94.